An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
By Susan M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, F. Fezza, M. Tognetto, Timothy J. Petros, J. Krey, Constance J. Chu and 5 more. Proceedings of the National Academy of Sciences of the United States of America, 2002
1,000 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Physiology, Sensory Systems
View Paper: https://www.semanticscholar.org/paper/32d9e7b23e0a0bff4508494351fd9d3715a3b886
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Physiology
In Sensory Systems
Citations in the corpus
- Paracetamol: new vistas of an old drug. (2006, background): “AM404 belongs to the group of bioactive N-acylamines that includes the endogenous lipid anandamide (arachidonoyl-ethanolamide, AEA) (69), N-arachidonoyldopamine (106), and N-arachidonoylglycine (105), the synthetic compounds: olvanil (109), arvanil (136), linvanil (66,136), and others (66,136).”
- The emerging role of the endocannabinoid system in endocrine regulation and energy balance. (2006, neutral): “Specifically, these compounds are 2-arachidonoyl-glyceryl-ether (noladin ether) (92), O-arachidonoyl-ethanolamine (virodhamine) (93), N-arachidonoyl-dopamine (94), and possibly oleamide (95).”
- Anandamide and vanilloid TRPV1 receptors (2003, background): “Indeed, a high efficacy TRPV1 agonist, N-arachidonoyldopamine (NADA), has recently been isolated from the central nervous system (Huang et al., 2002).”